These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26427609)

  • 1. Increased levels of MIP-1α in CSF and serum of ALS.
    Yang X; Gao L; Wu X; Zhang Y; Zang D
    Acta Neurol Scand; 2016 Aug; 134(2):94-100. PubMed ID: 26427609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the levels of CSF and serum factors in ALS.
    Guo J; Yang X; Gao L; Zang D
    Brain Behav; 2017 Mar; 7(3):e00637. PubMed ID: 28293476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Liu J; Gao L; Zang D
    PLoS One; 2015; 10(9):e0136937. PubMed ID: 26332465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased cerebrospinal fluid levels of cytokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1β (MIP-1β) in patients with amyotrophic lateral sclerosis.
    Martínez HR; Escamilla-Ocañas CE; Camara-Lemarroy CR; González-Garza MT; Moreno-Cuevas J; García Sarreón MA
    Neurologia (Engl Ed); 2020 Apr; 35(3):165-169. PubMed ID: 29029824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.
    Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL
    Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden.
    Simpson EP; Henry YK; Henkel JS; Smith RG; Appel SH
    Neurology; 2004 May; 62(10):1758-65. PubMed ID: 15159474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
    Xu Z; Henderson RD; David M; McCombe PA
    PLoS One; 2016; 11(10):e0164625. PubMed ID: 27732645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF levels in CSF and serum in mild ALS patients.
    Gao L; Zhou S; Cai H; Gong Z; Zang D
    J Neurol Sci; 2014 Nov; 346(1-2):216-20. PubMed ID: 25204587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis.
    Nukui T; Matsui A; Niimi H; Sugimoto T; Hayashi T; Dougu N; Konishi H; Yamamoto M; Anada R; Matsuda N; Kitajima I; Nakatsuji Y
    BMC Neurol; 2021 Jun; 21(1):255. PubMed ID: 34193068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.
    Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR
    JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Oxidation-Reduction Potential of Cerebrospinal Fluid Be a Monitoring Biomarker in Amyotrophic Lateral Sclerosis?
    Opačić M; Stević Z; Baščarević V; Živić M; Spasić M; Spasojević I
    Antioxid Redox Signal; 2018 Jun; 28(17):1570-1575. PubMed ID: 29113448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.
    Mitchell RM; Freeman WM; Randazzo WT; Stephens HE; Beard JL; Simmons Z; Connor JR
    Neurology; 2009 Jan; 72(1):14-9. PubMed ID: 18987350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression.
    Femiano C; Bruno A; Gilio L; Buttari F; Dolcetti E; Galifi G; Azzolini F; Borrelli A; Furlan R; Finardi A; Musella A; Mandolesi G; Storto M; Centonze D; Stampanoni Bassi M
    Sci Rep; 2024 Aug; 14(1):19796. PubMed ID: 39187524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral factors in ALS patients during disease progression.
    Ehrhart J; Smith AJ; Kuzmin-Nichols N; Zesiewicz TA; Jahan I; Shytle RD; Kim SH; Sanberg CD; Vu TH; Gooch CL; Sanberg PR; Garbuzova-Davis S
    J Neuroinflammation; 2015 Jun; 12():127. PubMed ID: 26126965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cerebrospinal fluid values of advanced oxidation protein products and total thiol content in patients with amyotrophic lateral sclerosis.
    Djordjevic G; Ljubisavljevic S; Sretenovic S; Kocic G; Stojanovic I; Stojanovic S
    Clin Neurol Neurosurg; 2017 Dec; 163():33-38. PubMed ID: 29055222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.